Piramal Pharma Ltd

NSE: PPLPHARMA · BSE: 543635 · Pharmaceuticals & Biotechnology · 43 announcements

Share price: ₹248.95
Market cap: ₹33,144 Cr
Revenue (annual): ₹8,869 Cr
Net profit (annual): ₹-325.9 Cr
P/E (TTM): -158.7×Sector 43.8×
Promoter holding: 34.80%+0.00% QoQ
FII holding: 13.65%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Price Movement Clarification 2 Other Announcement 2 Results Update 1 Management Change 1 Legal & Regulatory 1 Financial Results 1 Earnings Call 1 Capital Structure Change 1 Business Update 1 Board Meeting Date 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

29 Sep 2026 10:58 IST NSE

Legal & Regulatory

Piramal Pharma Legal & Regulatory

Piramal Pharma Limited received a GST demand and equivalent penalty totaling Rs. 8.12 Crore from tax authorities. The company intends to appeal the order, contesting the eligibility of certain input tax credits.

Value: ₹8.12 Cr

Open announcement → Read the filing ↗